IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis

Mucosal Immunology

Volumn 7, Issue 4, 2014, Pages 869-878

  Li, B ^a   Alli, R ^a   Vogel, P ^a   Geiger, T L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 10 RECEPTOR ALPHA; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SYNTHESIS; IMMUNOMODULATION; LAMINA PROPRIA; MACROPHAGE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; MACROPHAGES; MICE; MICE, KNOCKOUT; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 84902588276     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.103     Document Type: Article

References (47)

1. Arai, Y., Takanashi, H., Kitagawa, H. & Okayasu, I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 10, 890-896 (1998
2. Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn Disease and experimental colitis in vivo. Nat. Med. 6, 583-588 (2000
3. Simpson, S.J. et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187, 1225-1234 (1998
4. Yang, X.O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (2008
5. Kojouharoff, G. et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin. Exp. Immunol. 107, 353-358 (1997
6. Maloy, K.J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011
7. Glocker, E.O., Kotlarz, D., Klein, C., Shah, N. & Grimbacher, B. IL-10 and IL-10 receptor defects in humans. Ann. NY Acad. Sci. 1246, 102-107 (2011
8. Glocker, E.O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045 (2009
9. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993
10. Spencer, S.D. et al. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187, 571-578 (1998
11. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R.S. & Bhan, A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002
12. Powrie, F. et al. Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553-562 (1994
13. Tomoyose, M.,Mitsuyama, K., Ishida, H., Toyonaga, A. &Tanikawa, K. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. 33, 435-440 (1998
14. Ouyang, W., Rutz, S., Crellin, N.K., Valdez, P.A. & Hymowitz, S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71-109 (2011
15. Moore, K.W., deWaal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001
16. Mosser, D.M. & Zhang, X. Interleukin-10: New perspectives on an old cytokine. Immunol. Rev. 226, 205-218 (2008
17. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010
18. Liu, X. et al. The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunity. J. Immunol. 189, 669-678 (2011
19. Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999
20. Daley, J.M., Thomay, A.A., Connolly,M.D., Reichner, J.S. & Albina, J.E.Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70 (2008
21. Zaki, M.H. et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010
22. Takada, Y. et al. Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset. J. Immunol. 184, 2671-2676 (2010
23. Rivollier, A., He, J., Kole, A., Valatas, V. & Kelsall, B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155 (2012
24. Ito, R. et al. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377, 12-16 (2008
25. Dharmani, P., Leung, P. & Chadee, K. Tumor necrosis factor-Alpha and Muc2 mucin play major roles in Disease onset and progression in Dextran sodium sulphate-induced colitis. PLoS One 6, e25058 (2011
26. Cross, R.K. & Wilson, K.T. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9, 179-189 (2003
27. Laroux, F.S., Romero, X., Wetzler, L., Engel, P. & Terhorst, C. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gramnegative bacteria. J. Immunol. 175, 5596-5600 (2005
28. Krieglstein, C.F. et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide. J. Exp. Med. 194, 1207-1218 (2001
29. Hoshi, N. et al.MyD88 signalling in colonicmononuclear phagocytes drives colitis in IL-10-deficient mice. Nat. Commun. 3, 1120 (2012
30. Takeda, K. et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49 (1999
31. Murai, M. et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10, 1178-1184 (2009
32. Huber, S. et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34, 554-565 (2011
33. Dieleman, L.A. et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994
34. Axelsson, L.G., Landstrom, E., Goldschmidt, T.J., Gronberg, A. & Bylund-Fellenius, A.C. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 45, 181-191 (1996
35. Waddell, A. et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/ macrophagederived CCL11. J. Immunol. 186, 5993-6003 (2011
36. Mahida, Y.R. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 6, 21-33 (2000
37. Benoit, M., Desnues, B. & Mege, J.L. Macrophage polarization in bacterial infections. J. Immunol. 181, 3733-3739 (2008
38. Xie, Q.W. et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228 (1992
39. McCafferty, D.M., Mudgett, J.S., Swain, M.G. & Kubes, P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112, 1022-1027 (1997
40. Hokari, R. et al. Reduced sensitivity of inducible nitric oxide synthasedeficient mice to chronic colitis. Free Radic. Biol. Med. 31, 153-163 (2001
41. Kolios, G., Valatas, V. & Ward, S.G. Nitric oxide in inflammatory bowel disease: A universal messenger in an unsolved puzzle. Immunology 113, 427-437 (2004
42. Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007
43. Medina-Contreras, O. et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J. Clin. Invest. 121, 4787-4795 (2011
44. Garg, P. et al. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: Contrasting role of gelatinases in the pathogenesis of colitis. J. Immunol. 177, 4103-4112 (2006
45. Tsuchiya, T. et al. Role of gamma delta Tcells in the inflammatory response of experimental colitis mice. J. Immunol. 171, 5507-5513 (2003
46. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticusinduced T cell-dependent colitis. J. Exp. Med. 203, 2485-2494 (2006
47. Yang, K., Neale, G., Green, D.R., He, W. & Chi, H. The tumor suppressor Tsc1 enforces quiescence of naive Tcells to promote immune homeostasis and function. Nat. Immunol. 12, 888-897 (2011.